COVID-19 vaccine hesitancy: Race/ethnicity, trust, and fear
- PMID: 34213073
- PMCID: PMC8444681
- DOI: 10.1111/cts.13077
COVID-19 vaccine hesitancy: Race/ethnicity, trust, and fear
Abstract
Understanding and minimizing coronavirus disease 2019 (COVID-19) vaccine hesitancy is critical to population health and minimizing health inequities, which continue to be brought into stark relief by the pandemic. We investigate questions regarding vaccine hesitancy in a sample (n = 1205) of Arkansas adults surveyed online in July/August of 2020. We examine relationships among sociodemographics, COVID-19 health literacy, fear of COVID-19 infection, general trust in vaccines, and COVID-19 vaccine hesitancy using bivariate analysis and a full information maximum likelihood (FIML) logistic regression model. One in five people (21,21.86%) reported hesitancy to take a COVID-19 vaccine. Prevalence of COVID-19 vaccine hesitancy was highest among Black/African Americans (50.00%), respondents with household income less than $25K (30.68%), some college (32.17%), little to no fear of infection from COVID-19 (62.50%), and low trust in vaccines in general (55.84%). Odds of COVID-19 vaccine hesitancy were 2.42 greater for Black/African American respondents compared to White respondents (p < 0.001), 1.67 greater for respondents with some college/technical degree compared to respondents with a 4-year degree (p < 0.05), 5.48 greater for respondents with no fear of COVID-19 infection compared to those who fear infection to a great extent (p < 0.001), and 11.32 greater for respondents with low trust in vaccines (p < 0.001). Sociodemographic differences in COVID-19 vaccine hesitancy raise concerns about the potential of vaccine implementation to widen existing health disparities in COVID-19 related infections, particularly among Black/African Americans. Fear of infection and general mistrust in vaccines are significantly associated with vaccine hesitancy.
© 2021 The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of the American Society for Clinical Pharmacology and Therapeutics.
Conflict of interest statement
The authors declare no competing interests for this work.
References
-
- Yancy CW. COVID‐19 and African Americans. JAMA. 2020;323:1891–1892. - PubMed
-
- Healy J, Harmon A, Romero S, et al. ‘The weapon that will end the war’: Vaccinations begin across virus‐ravaged America. The New York Times; 2020.
-
- MacDonald NE, SAGE Working Group on Vaccine . Hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33:4161–4164. - PubMed
-
- Funk C, Tyson A. Intent to Get a COVID‐19 Vaccine Rises to 60% as Confidence in Research and Development Process Increases; 2020.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
